When do we need to suspect maturity onset diabetes of the young in patients with type 2 diabetes mellitus?

Detalhes bibliográficos
Autor(a) principal: Üstay,Özlem
Data de Publicação: 2022
Outros Autores: Ateş,Esra Arslan, Apaydin,Tugçe, Elbasan,Onur, Polat,Hamza, Günhan,Gizem, Dinçer,Ceyda, Şeker,Lamia, Yabacı,Ayşegül, Güney,Ahmet Ilter, Yavuz,Dilek Gogas
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Arquivos de Endocrinologia e Metabolismo (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972022000100032
Resumo: ABSTRACT Objetivo: Maturity onset diabetes of the young (MODY) patients have clinical heterogeneity as shown by many studies. Thus, often it is misdiagnosed to type 1 or type 2 diabetes(T2DM). The aim of this study is to evaluate MODY mutations in adult T2DM patients suspicious in terms of MODY, and to show clinical and laboratory differences between these two situations. Subjects and methods: In this study, we analyzed 72 type 2 diabetic patients and their relatives (35F/37M) who had been suspected for MODY and referred to genetic department for mutation analysis. The gene mutations for MODY have been assessed in the laboratory of Marmara University genetics. Totally 67 (32F/35M; median age 36.1) diabetic patients were analyzed for 7 MODY mutations. Twelve patients who have uncertain mutation (VUS) were excluded from study for further evaluation. MODY(+) (n:30) patients and T2DM patients (n:25) were compared for clinical and laboratory parameters. Results: In MODY(+) subjects, mutations in GCK (MODY 2) (n:12; 40%) were the most common followed by HNF4A (MODY 1) (n:4; 13.3%). Diabetes diagnosis age was younger in MODY(+) group but not statistically significant. Sixty-six percent of MODY(+) subjects had diabetes history at 3-consecutive generations in their family compared with 28% of T2DM patients statistically significant (p:0.006). Gender, BMI, C-peptide, HbA1c, lipid parameters, creatinine, GFR, microalbuminuria, vitamin D and calcium were not statistically different between the groups. Conclusion: According to present study results, MODY mutation positivity is most probable in young autoantibody (-) diabetic patients diagnosed before 30 years of age, who have first degree family history of diabetes.
id SBEM-1_72dc1d3de3d2e7a5b66dfeaee3f904b9
oai_identifier_str oai:scielo:S2359-39972022000100032
network_acronym_str SBEM-1
network_name_str Arquivos de Endocrinologia e Metabolismo (Online)
repository_id_str
spelling When do we need to suspect maturity onset diabetes of the young in patients with type 2 diabetes mellitus?MODYmaturity onset diabetes of the youngearly onset type 2 diabetesABSTRACT Objetivo: Maturity onset diabetes of the young (MODY) patients have clinical heterogeneity as shown by many studies. Thus, often it is misdiagnosed to type 1 or type 2 diabetes(T2DM). The aim of this study is to evaluate MODY mutations in adult T2DM patients suspicious in terms of MODY, and to show clinical and laboratory differences between these two situations. Subjects and methods: In this study, we analyzed 72 type 2 diabetic patients and their relatives (35F/37M) who had been suspected for MODY and referred to genetic department for mutation analysis. The gene mutations for MODY have been assessed in the laboratory of Marmara University genetics. Totally 67 (32F/35M; median age 36.1) diabetic patients were analyzed for 7 MODY mutations. Twelve patients who have uncertain mutation (VUS) were excluded from study for further evaluation. MODY(+) (n:30) patients and T2DM patients (n:25) were compared for clinical and laboratory parameters. Results: In MODY(+) subjects, mutations in GCK (MODY 2) (n:12; 40%) were the most common followed by HNF4A (MODY 1) (n:4; 13.3%). Diabetes diagnosis age was younger in MODY(+) group but not statistically significant. Sixty-six percent of MODY(+) subjects had diabetes history at 3-consecutive generations in their family compared with 28% of T2DM patients statistically significant (p:0.006). Gender, BMI, C-peptide, HbA1c, lipid parameters, creatinine, GFR, microalbuminuria, vitamin D and calcium were not statistically different between the groups. Conclusion: According to present study results, MODY mutation positivity is most probable in young autoantibody (-) diabetic patients diagnosed before 30 years of age, who have first degree family history of diabetes.Sociedade Brasileira de Endocrinologia e Metabologia2022-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972022000100032Archives of Endocrinology and Metabolism v.66 n.1 2022reponame:Arquivos de Endocrinologia e Metabolismo (Online)instname:Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)instacron:SBEM10.20945/2359-3997000000431info:eu-repo/semantics/openAccessÜstay,ÖzlemAteş,Esra ArslanApaydin,TugçeElbasan,OnurPolat,HamzaGünhan,GizemDinçer,CeydaŞeker,LamiaYabacı,AyşegülGüney,Ahmet IlterYavuz,Dilek Gogaseng2022-05-11T00:00:00Zoai:scielo:S2359-39972022000100032Revistahttps://www.aem-sbem.com/https://old.scielo.br/oai/scielo-oai.php||aem.editorial.office@endocrino.org.br2359-42922359-3997opendoar:2022-05-11T00:00Arquivos de Endocrinologia e Metabolismo (Online) - Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)false
dc.title.none.fl_str_mv When do we need to suspect maturity onset diabetes of the young in patients with type 2 diabetes mellitus?
title When do we need to suspect maturity onset diabetes of the young in patients with type 2 diabetes mellitus?
spellingShingle When do we need to suspect maturity onset diabetes of the young in patients with type 2 diabetes mellitus?
Üstay,Özlem
MODY
maturity onset diabetes of the young
early onset type 2 diabetes
title_short When do we need to suspect maturity onset diabetes of the young in patients with type 2 diabetes mellitus?
title_full When do we need to suspect maturity onset diabetes of the young in patients with type 2 diabetes mellitus?
title_fullStr When do we need to suspect maturity onset diabetes of the young in patients with type 2 diabetes mellitus?
title_full_unstemmed When do we need to suspect maturity onset diabetes of the young in patients with type 2 diabetes mellitus?
title_sort When do we need to suspect maturity onset diabetes of the young in patients with type 2 diabetes mellitus?
author Üstay,Özlem
author_facet Üstay,Özlem
Ateş,Esra Arslan
Apaydin,Tugçe
Elbasan,Onur
Polat,Hamza
Günhan,Gizem
Dinçer,Ceyda
Şeker,Lamia
Yabacı,Ayşegül
Güney,Ahmet Ilter
Yavuz,Dilek Gogas
author_role author
author2 Ateş,Esra Arslan
Apaydin,Tugçe
Elbasan,Onur
Polat,Hamza
Günhan,Gizem
Dinçer,Ceyda
Şeker,Lamia
Yabacı,Ayşegül
Güney,Ahmet Ilter
Yavuz,Dilek Gogas
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Üstay,Özlem
Ateş,Esra Arslan
Apaydin,Tugçe
Elbasan,Onur
Polat,Hamza
Günhan,Gizem
Dinçer,Ceyda
Şeker,Lamia
Yabacı,Ayşegül
Güney,Ahmet Ilter
Yavuz,Dilek Gogas
dc.subject.por.fl_str_mv MODY
maturity onset diabetes of the young
early onset type 2 diabetes
topic MODY
maturity onset diabetes of the young
early onset type 2 diabetes
description ABSTRACT Objetivo: Maturity onset diabetes of the young (MODY) patients have clinical heterogeneity as shown by many studies. Thus, often it is misdiagnosed to type 1 or type 2 diabetes(T2DM). The aim of this study is to evaluate MODY mutations in adult T2DM patients suspicious in terms of MODY, and to show clinical and laboratory differences between these two situations. Subjects and methods: In this study, we analyzed 72 type 2 diabetic patients and their relatives (35F/37M) who had been suspected for MODY and referred to genetic department for mutation analysis. The gene mutations for MODY have been assessed in the laboratory of Marmara University genetics. Totally 67 (32F/35M; median age 36.1) diabetic patients were analyzed for 7 MODY mutations. Twelve patients who have uncertain mutation (VUS) were excluded from study for further evaluation. MODY(+) (n:30) patients and T2DM patients (n:25) were compared for clinical and laboratory parameters. Results: In MODY(+) subjects, mutations in GCK (MODY 2) (n:12; 40%) were the most common followed by HNF4A (MODY 1) (n:4; 13.3%). Diabetes diagnosis age was younger in MODY(+) group but not statistically significant. Sixty-six percent of MODY(+) subjects had diabetes history at 3-consecutive generations in their family compared with 28% of T2DM patients statistically significant (p:0.006). Gender, BMI, C-peptide, HbA1c, lipid parameters, creatinine, GFR, microalbuminuria, vitamin D and calcium were not statistically different between the groups. Conclusion: According to present study results, MODY mutation positivity is most probable in young autoantibody (-) diabetic patients diagnosed before 30 years of age, who have first degree family history of diabetes.
publishDate 2022
dc.date.none.fl_str_mv 2022-02-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972022000100032
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972022000100032
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.20945/2359-3997000000431
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Endocrinologia e Metabologia
publisher.none.fl_str_mv Sociedade Brasileira de Endocrinologia e Metabologia
dc.source.none.fl_str_mv Archives of Endocrinology and Metabolism v.66 n.1 2022
reponame:Arquivos de Endocrinologia e Metabolismo (Online)
instname:Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
instacron:SBEM
instname_str Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
instacron_str SBEM
institution SBEM
reponame_str Arquivos de Endocrinologia e Metabolismo (Online)
collection Arquivos de Endocrinologia e Metabolismo (Online)
repository.name.fl_str_mv Arquivos de Endocrinologia e Metabolismo (Online) - Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
repository.mail.fl_str_mv ||aem.editorial.office@endocrino.org.br
_version_ 1752122518913679360